학술논문
DARATUMUMAB (DARA), CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE: A QUADRUPLET INTENSIFIED TREATMENT FOR TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA (TE NDMM) PATIENTS
Document Type
Abstract
Author
Source
In Hematology, Transfusion and Cell Therapy October 2021 43 Supplement 1:S194-S195
Subject
Language
ISSN
2531-1379